Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06187662 · ClinicalTrials.gov registry record · NA

BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches

A NA study of Implementation Science and Antibiotic Stewardship, sponsored by Children's Hospital of Philadelphia.

Active
Registry status
NA
Development phase
8
Enrollment target
8
Study locations

NCT06187662: Active NA study of Implementation Science and Antibiotic Stewardship, sponsored by Children's Hospital of Philadelphia.

NCT06187662 is a NA study of Implementation Science and Antibiotic Stewardship that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 8 participants, below the 1,743-participant average among 13 other Implementation Science trials with a reported enrollment target (100% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06187662, a NA study of Implementation Science and Antibiotic Stewardship, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
8
Study locations

Study Summary

This study will compare two strategies that target distinct determinants of blood culture overuse in an exploratory, hybrid, pilot trial in 8 PICUs. It aims to determine if there is any association between specific strategies used to reduce blood culture overuse on unit-wide blood culture rates, patient safety, and concurrently explore aspects of the implementation process (acceptability, feasibility, appropriateness).

Primary Outcome

Compare differences in clinical outcomes, via total blood culture rates, before and after intervention, as well as between intervention arms

Interventions

  • BEHAVIORAL Checklist
  • BEHAVIORAL Targeted Messaging

Study Locations (8)

California

  • UCLA Mattel Children's Hospital - Los Angeles
  • UCSF Benioff Children's Hospital Mission Bay - San Francisco

New York

  • Kravis Children's Hospital - New York
  • New York-Presbyterian Morgan Stanley Children's Hospital - New York

Delaware

  • Nemours / AI DuPont Hospital for Children - Wilmington

Indiana

  • Riley Hospital for Children - Indianapolis

Kentucky

  • Norton Children's Hospital - Louisville

Wisconsin

  • Children's Hospital of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2023-01-01
Est. Completion 2027-04
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the registry record for NCT06187662 still lists

NCT06187662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,743-participant average among 13 other Implementation Science trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Implementation Science appearing as the primary indexed condition, and to 2 interventions - of which Checklist is the first listed.

NCT06187662 lists 8 locations in 6 states (California, New York, Delaware).

Frequently Asked Questions

What is clinical trial NCT06187662 about?

NCT06187662 is a clinical study titled "BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches". This study will compare two strategies that target distinct determinants of blood culture overuse in an exploratory, hybrid, pilot trial in 8 PICUs. It aims to determine if there is any association between specific strategies used to reduce blood culture overuse on unit-wide blood culture rates, pat...

What is the current status of trial NCT06187662?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2023-01-01. Estimated completion is 2027-04.

What conditions does trial NCT06187662 study?

This clinical trial studies the following conditions: Implementation Science, Antibiotic Stewardship, Blood Culture Rates.

What interventions are being tested in trial NCT06187662?

The interventions under investigation include: Checklist (BEHAVIORAL), Targeted Messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT06187662?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06187662 being conducted?

This trial has 8 study locations across California, Delaware, Indiana, Kentucky, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Implementation Science

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06187662's enrollment target sits among peer trials

8 13th of 13 higher than 1 of 13 other Implementation Science trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Implementation Science trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06187662, the US trial registry maintained by the National Library of Medicine. NCT06187662 (small enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.